Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular Targeting of the Fibroblast Growth Factor Receptor Pathway across Various Cancers
Khine Shan, Shivani Dalal, Nyein Nyein Thaw Dar, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 849-849
Open Access | Times Cited: 11

Showing 11 citing articles:

Emerging Targeted Therapies in Non-Small-Cell Lung Cancer (NSCLC)
Syeda A. Mina, Mohamed Shanshal, Konstantinos Leventakos, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 353-353
Open Access | Times Cited: 1
Diphenyl urea‐benzylidene acetohydrazide hybrids as fibroblast growth factor receptor 1 inhibitors and anticancer agents
Heba T. Abdel‐Mohsen, Amira M. Nageeb, Iman A. Y. Ghannam
Drug Development Research (2024) Vol. 85, Iss. 6
Closed Access | Times Cited: 4
Cell membrane sialome machinery and regulation of receptor tyrosine kinases in gliomas: The functional relevance and therapeutic perspectives
Patrycja Jastrząb, Halina Car, Przemysław Wielgat
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117921-117921
Closed Access
Fibroblast growth factor receptor signaling in metabolic dysfunction-associated fatty liver disease: Pathogenesis and therapeutic targets
Yi Chu, Yang Su, Xiaodong Chen
Pharmacology & Therapeutics (2025), pp. 108844-108844
Closed Access
Unlocking novel therapeutic avenues in glioblastoma: Harnessing 4-amino cyanine and miRNA synergy for next-gen treatment convergence
K Sandhanam, Tamilanban Thamaraikani, K. Manasa, et al.
Neuroscience (2024) Vol. 553, pp. 1-18
Closed Access | Times Cited: 4
Fibroblast growth factor receptor signaling in estrogen receptor-positive breast cancer: mechanisms and role in endocrine resistance
Arnaldo Marín, Fernanda Morales, Benjamín Walbaum
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
FGFR Inhibitors in Urothelial Cancer: From Scientific Rationale to Clinical Development
Whi‐An Kwon
Journal of Korean Medical Science (2024) Vol. 39, Iss. 43
Open Access | Times Cited: 1
Fibroblast Growth Factor Receptor Inhibitors Decrease Proliferation of Melanoma Cell Lines and Their Activity Is Modulated by Vitamin D
Anna Piotrowska, Joanna I. Nowak, Justyna Wierzbicka, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2505-2505
Open Access
Precision oncology targeting FGFRs: A systematic review on pre-clinical activity and clinical outcomes of pemigatinib
Ludovica Gnagni, Ilary Ruscito, Ilaria Grazia Zizzari, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 202, pp. 104464-104464
Open Access
Organotin exposure and DNA methylation in non-syndromic cleft lip and palate: Integrating findings from case-control studies and animal experiments
Yongyan Chen, Qianhui Cheng, Sainan Li, et al.
The Science of The Total Environment (2024) Vol. 954, pp. 176214-176214
Closed Access
Receptor tyrosine kinases and steroid hormone receptors in breast cancer: Review of recent evidences
Awgichew Behaile Teklemariam, Zelalem Tilahun Muche, Melaku Mekonnen Agidew, et al.
Metabolism Open (2024) Vol. 24, pp. 100324-100324
Open Access
Page 1

Scroll to top